Healthcare

Analyzing Ownership Dynamics in Avacta Group Plc (LON:AVCT)

Highlights,Individual investors hold 57% of,Avacta,Group Plc (,LON:AVCT,),,benefitting,most from stock movements.,Institutional investors, owning 41%,...

Synairgen Secures Conditional £18 Million Funding for Key Clinical T...

Highlights:,Major Funding Secured:,Synairgen raises £18 million conditionally through TFG Asset Management, with an additional £6 million targeted thr...

NIOX Group's Impressive Five-Year Performance

Highlights,NIOX Group (NIOX) shares surged by 237% over the past five years.,Profitability marked a significant inflection point, contributing to stro...

Hemogenyx Partners with Kure.ai to Revolutionise CAR-T Cell Therapy...

Highlights:,Hemogenyx partners with Kure.ai to develop an ultrafast manufacturing (UM) process for CAR-T therapies.,The collaboration targets faster,...

Understanding Oxford Nanopore Technologies' (LON:ONT) Elevated P/S R...

Highlights,High P/S Ratio,Oxford Nanopore Technologies (ONT) has a price-to-sales (P/S) ratio of 8.1x, significantly higher than the industry average....

Intelligent Ultrasound Group Agrees to £45M Acquisition by Surgical...

Highlights:,Intelligent Ultrasound Group PLC to be acquired by Surgical Science Sweden in a £45 million cash deal.,The offer represents a 17% premium...

Surgical Science Announces £45.2 Million Acquisition of Intelligent...

Highlights,Surgical Science Sweden AB to acquire Intelligent Ultrasound Group plc for £45.2 million in a cash deal.,Acquisition represents a premium o...

Pfizer Signals Stability with 2025 Growth Guidance Amid Investor Con...

Highlights:,Revenue Growth Forecast:,Pfizer expects up to 5% revenue growth, aligning with market expectations.,Earnings Outlook Strong:,Per-share ear...

ANGLE’s Parsortix System Gains Validation in HER2 Breast Cancer Test...

Highlights:,Independent study validates the Parsortix system for HER2-positive breast cancer testing.,HER2 status shifts identified in circulating tum...

Institutional Ownership at PureTech Health plc (LON:PRTC)

Highlights,71% of PureTech Health’s stock is held by institutional investors.,Invesco Ltd. is the largest shareholder with 17% ownership.,Insider owne...

Genus (LON:GNS) Stock Performance and Recent Developments

Highlights,Genus (GNS) stock has fluctuated between GBX 1,478 and GBX 2,378 over the past year.,The company operates in the animal genetics industry a...

hVIVO Publishes World-First COVID-19 Characterisation Study in Natur...

Highlights:,First-of-its-kind COVID-19 characterisation trial identifies key blood biomarkers.,Study confirms safety and detailed progression insights...

HUTCHMED (China) Limited (AIM: HCM; HKEX: 13) Receives Breakthrough...

Highlights,HUTCHMED's combination of ORPATHYS® and TAGRISSO® receives Breakthrough Therapy Designation (BTD) from NMPA.,Combination treatment aims to...

Indivior (LON:INDV) Sees Decline Amid Reduced Trading Activity

Highlights,Indivior (INDV) shares fell by 1.2% on Wednesday.,Trading volume saw a drastic drop, with shares down by 81%.,The company faces significant...

EKF Diagnostics (LON:EKF) Sees Positive Movement in Stock Price

Highlights,Stock price rose by 0.8%,on Wednesday, showing positive momentum for EKF Diagnostics (EKF).,Increased trading volume by over 1,000%,signals...

Uniphar (LON:UPR) Faces a 1.1% Drop in Stock Price Amid Reduced Trad...

Highlights,Uniphar (UPR) shares dropped by 1.1% on Wednesday.,Trading volume significantly decreased by 82%, signaling reduced market activity.,The st...

Genus plc (LON:GNS) Sees Positive Movement Despite Insider Activity

Highlights,Genus (GNS) shares rose by 1.1% on Wednesday.,Shore Capital upgraded Genus to a rating.,Insider Jorgen Kokke sold 2,186 shares at an averag...

hVIVO Signs £11.5 Million Contract with Global Pharma Client for RSV...

Highlights,hVIVO signs £11.5 million contract with a leading global pharmaceutical client for an RSV challenge trial.,The trial will evaluate an antiv...

GENinCode Partners with Genesupport to Expand Access to ROCA® Test i...

Highlights,GENinCode partners with Genesupport SA to expand ROCA® Test availability across Switzerland.,The ROCA Test, recommended by NICE in March 20...

Faron Pharmaceuticals Ltd. (AIM: FARN) Announces Positive Phase 2 Re...

Highlights,80% overall response rate (16 out of 20) in refractory/relapsed MDS patient population.,70% of patients achieved complete/partial response,...